Action	Date	Notes	Link
article xml file uploaded	15 January 2021 11:17 CET	Original file	-
article xml uploaded.	15 January 2021 11:17 CET	Update	https://www.mdpi.com/1422-0067/22/2/818/xml
article pdf uploaded.	15 January 2021 11:17 CET	Version of Record	https://www.mdpi.com/1422-0067/22/2/818/pdf
article supplementary file uploaded.	15 January 2021 11:17 CET	-	https://www.mdpi.com/1422-0067/22/2/818#supplementary
article html file updated	15 January 2021 11:19 CET	Original file	-
article html file updated	23 July 2022 16:56 CEST	Update	https://www.mdpi.com/1422-0067/22/2/818/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Nasiri-Ansari, N.; Nikolopoulou, C.; Papoutsi, K.; Kyrou, I.; Mantzoros, C.S.; Kyriakopoulos, G.; Chatzigeorgiou, A.; Kalotychou, V.; Randeva, M.S.; Chatha, K.; et al. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE^(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis. Int. J. Mol. Sci. 2021, 22, 818. https://doi.org/10.3390/ijms22020818

AMA Style

Nasiri-Ansari N, Nikolopoulou C, Papoutsi K, Kyrou I, Mantzoros CS, Kyriakopoulos G, Chatzigeorgiou A, Kalotychou V, Randeva MS, Chatha K, et al. Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE^(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis. International Journal of Molecular Sciences. 2021; 22(2):818. https://doi.org/10.3390/ijms22020818

Chicago/Turabian Style

Nasiri-Ansari, Narjes, Chrysa Nikolopoulou, Katerina Papoutsi, Ioannis Kyrou, Christos S. Mantzoros, Georgios Kyriakopoulos, Antonios Chatzigeorgiou, Vassiliki Kalotychou, Manpal S. Randeva, Kamaljit Chatha, and et al. 2021. "Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE^(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis" International Journal of Molecular Sciences 22, no. 2: 818. https://doi.org/10.3390/ijms22020818

APA Style

Nasiri-Ansari, N., Nikolopoulou, C., Papoutsi, K., Kyrou, I., Mantzoros, C. S., Kyriakopoulos, G., Chatzigeorgiou, A., Kalotychou, V., Randeva, M. S., Chatha, K., Kontzoglou, K., Kaltsas, G., Papavassiliou, A. G., Randeva, H. S., & Kassi, E. (2021). Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE^(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis. International Journal of Molecular Sciences, 22(2), 818. https://doi.org/10.3390/ijms22020818

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Printed Edition

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI